NCT06750809View on ClinicalTrials.gov

Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 21, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

February 28, 2026

Conditions
Surgical WoundTrauma WoundAutograftsPartial-thickness BurnPartial Thickness Wounds
Interventions
DEVICE

PermeaDerm Biosynthetic Wound Matrix

Study participants randomized (1:1) to this arm will receive PermeaDerm Biosynthetic Wound Matrix prior to skin graft.

DEVICE

Frozen Human Cadaveric Allograft (FHCA)

Study participant randomized (1:1) to this arm will receive Frozen Human Cadaveric Allograft (FHCA) prior to skin graft.

Trial Locations (9)

14642

NOT_YET_RECRUITING

University of Rochester, Rochester

27157

RECRUITING

Atrium Health Wake Forest Baptist, Winston-Salem

30303

RECRUITING

Grady Memorial, Atlanta

38163

RECRUITING

Regional One Firefighter's Burn Center, Memphis

43210

RECRUITING

Ohio State University, Columbus

44308

RECRUITING

Akron Children's Hospital, Akron

66160

RECRUITING

University of Kansas, Kansas City

70112

RECRUITING

University Medical Center, New Orleans

85008

RECRUITING

Valleywise Health, Phoenix

Sponsors

Lead Sponsor

Avita Medical
All Listed Sponsors
lead

Avita Medical

INDUSTRY

NCT06750809 - Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds | Biotech Hunter | Biotech Hunter